Simplified Chinese
Faithful to duty in a foreign land, the hero still awaits his triumphant anthem.
Release date:
2022-03-03
Author:
Source:
Abstract
Science brooks no falsehoods, and vaccine research and development must be conducted with the utmost rigor and adherence to established standards. Throughout the COVID‑19 vaccine development process, the company meticulously followed all relevant national procedures, completing domestic R&D and manufacturing in a scientifically sound and compliant manner, before promptly launching Phase III clinical trials in multiple overseas locations.
Although the company is undertaking its first overseas clinical trial, the team has brought with them the company’s work ethic—“no compromise, no luck, no procrastination; approach every task with diligence and integrity”—to a foreign land. township, and integrated it into the entire Phase III clinical program, thereby effectively ensuring both the quality and timely progress of the study. Among them, Comrade Liu Kai, Assistant to the Director of the Company’s Medical Department, stands out as an exemplary figure. Throughout the COVID‑19 clinical trials, he demonstrated unwavering dedication and meticulous attention to detail, traveling across multiple countries to expedite project completion. Even amid challenging circumstances—such as typhoons, pandemics, and sudden outbreaks of conflict—he remained undaunted, fulfilled his responsibilities with competence, and has become a distinguished embodiment of the company’s culture, truly worthy of our admiration. All employees should learn from him.
Since the escalation of the Russia-Ukraine conflict, the military situation on both sides has grown increasingly tense. Comrade Liu Kai, a member of our company’s COVID‑19 vaccine team stationed in Ukraine, disregarded his personal safety and, to ensure the continued progress of all operations, volunteered to remain at his post.
The company is closely monitoring developments in the Russia-Ukraine situation and maintains close communication with Comrade Liu Kai, serving as his strong support. Du, the company’s executive director, attaches great importance to Liu Kai’s safety and well-being in Ukraine, has repeatedly inquired about his condition, and has sent a personally signed letter of condolence, extending warm regards and heartfelt gratitude to him and his family. On behalf of the company, he also pledged to provide every possible assistance to ensure Liu Kai’s safe and early return home.
Comrade Liu Kai is an outstanding exemplar of the company’s corporate mission to “create better vaccines and benefit human health,” and deserves the heartfelt respect of all employees at Kintor and Minhai. We now call on every employee to learn from Comrade Liu Kai: to emulate his steadfast dedication to research and problem‑solving, his tenacious spirit in overcoming challenges; and to honor his noble qualities of unwavering commitment to duty, fearlessness in the face of hardship, and putting others before himself. Let us follow his example and make even greater contributions to the development of China’s vaccine industry and to the vaccine R&D efforts of Kintor and Minhai. Helping the world to overcome the COVID-19 pandemic at an early date.
Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account